title: Evaluation of a new high-dimensional miRNA profiling platform.
abstract: BACKGROUND
  MicroRNAs (miRNAs) are a class of approximately 22 nucleotide long, widely expressed RNA molecules that play important regulatory roles in eukaryotes. To investigate miRNA function, it is essential that methods to quantify their expression levels be available.
  
  
  METHODS
  We evaluated a new miRNA profiling platform that utilizes Illumina's existing robust DASL chemistry as the basis for the assay. Using total RNA from five colon cancer patients and four cell lines, we evaluated the reproducibility of miRNA expression levels across replicates and with varying amounts of input RNA. The beta test version was comprised of 735 miRNA targets of Illumina's miRNA profiling application.
  
  
  RESULTS
  Reproducibility between sample replicates within a plate was good (Spearman's correlation 0.91 to 0.98) as was the plate-to-plate reproducibility replicates run on different days (Spearman's correlation 0.84 to 0.98). To determine whether quality data could be obtained from a broad range of input RNA, data obtained from amounts ranging from 25 ng to 800 ng were compared to those obtained at 200 ng. No effect across the range of RNA input was observed.
  
  
  CONCLUSIONS
  These results indicate that very small amounts of starting material are sufficient to allow sensitive miRNA profiling using the Illumina miRNA high-dimensional platform. Nonlinear biases were observed between replicates, indicating the need for abundance-dependent normalization. Overall, the performance characteristics of the Illumina miRNA profiling system were excellent.
authors.affiliation: Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota, USA. cunningham.julie@mayo.edu
authors.forename: Julie M
authors.initials: JM
authors.lastname: Cunningham
authors.forename: Ann L
authors.initials: AL
authors.lastname: Oberg
authors.forename: Pedro M
authors.initials: PM
authors.lastname: Borralho
authors.forename: Betsy T
authors.initials: BT
authors.lastname: Kren
authors.forename: Amy J
authors.initials: AJ
authors.lastname: French
authors.forename: Liang
authors.initials: L
authors.lastname: Wang
authors.forename: Brian M
authors.initials: BM
authors.lastname: Bot
authors.forename: Bruce W
authors.initials: BW
authors.lastname: Morlan
authors.forename: Kevin A T
authors.initials: KA
authors.lastname: Silverstein
authors.forename: Rod
authors.initials: R
authors.lastname: Staggs
authors.forename: Yan
authors.initials: Y
authors.lastname: Zeng
authors.forename: Anne-Francoise
authors.initials: AF
authors.lastname: Lamblin
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Hilker
authors.forename: Jian-Bing
authors.initials: JB
authors.lastname: Fan
authors.forename: Clifford J
authors.initials: CJ
authors.lastname: Steer
authors.forename: Stephen N
authors.initials: SN
authors.lastname: Thibodeau